Vimarsana
Biggest News Aggregation in the World

Page 19 - Graphite Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Graphite Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Graphite Bio Today - Breaking & Trending Today

Graphite Bio, Inc. (NASDAQ:GRPH) Sees Significant Increase in Short Interest - Vimarsana News

Graphite Bio, Inc. (NASDAQ:GRPH) Sees Significant Increase in Short Interest

Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 4,030,000 shares, a growth of 33.0% from the March 15th total of 3,030,000 shares. Based on an average daily volume of 296,200 shares, the […]

Graphite Bio, Inc. (NASDAQ:GRPH) Insider Buys $20,050.00 in Stock - Vimarsana News

Graphite Bio, Inc. (NASDAQ:GRPH) Insider Buys $20,050.00 in Stock

Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) insider Phil Gutry purchased 5,000 shares of the stock in a transaction that occurred on Monday, April 11th. The shares were purchased at an average cost of $4.01 per share, with a total value of $20,050.00. Following the completion of the acquisition, the insider now owns 299,941 shares […]

Graphite Bio, Inc. (NASDAQ:GRPH) Major Shareholder Buys $303,068.48 in Stock - Vimarsana News

Graphite Bio, Inc. (NASDAQ:GRPH) Major Shareholder Buys $303,068.48 in Stock

Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) major shareholder Biocapital L.P. Samsara acquired 74,464 shares of the firm’s stock in a transaction that occurred on Monday, April 11th. The stock was acquired at an average price of $4.07 per share, with a total value of $303,068.48. Following the completion of the acquisition, the insider now […]

Brokerages Set Graphite Bio, Inc. (NASDAQ:GRPH) Target Price at $18.00 - Vimarsana News

Brokerages Set Graphite Bio, Inc. (NASDAQ:GRPH) Target Price at $18.00

Shares of Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) have been given an average rating of “Buy” by the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1 […]

These Were The Ten Worst Performing Small-Cap Stocks In March 2022 - Vimarsana News

These Were The Ten Worst Performing Small-Cap Stocks In March 2022

We have used the March return data of small-cap stocks to rank the ten worst performing small-cap stocks in March 2022.